Table 1.
Category | Uncemented implant (n = 4319) | Cemented implant (n = 2179) | p value* |
---|---|---|---|
Followup (years), mean (SD) | 5.6 (4.8) | 10.5 (5.3) | < 0.0001 |
Age (years), mean (SD) | 62.1 (12.1) | 71.9 (10.2) | < 0.0001 |
Cost of implant, mean (SD) | $6074 ($1313) | $4491 ($1646) | < 0.0001 |
Sex | |||
Male | 2055 (48%) | 742 (34%) | < 0.0001 |
Female | 2264 (52%) | 1437 (66%) | |
Age categories (years) | |||
< 55 | 1119 (26%) | 141 (6%) | < 0.0001 |
55–70 | 2051 (47%) | 699 (32%) | |
> 70 | 1149 (27%) | 1339 (61%) | |
Procedural timeframe | |||
1991–1998 | 513 (12%) | 1079 (50%) | < 0.0001 |
1999–2004 | 946 (22%) | 787 (36%) | |
2005–2011 | 2860 (66%) | 313 (14%) | |
Primary diagnosis | |||
Osteoarthritis | 3940 (91%) | 1958 (90%) | 0.07 |
Aseptic necrosis | 201 (5%) | 104 (5%) | |
Other | 178 (4%) | 117 (5%) | |
Stem revision reason | |||
Loosening related to wear/osteolysis | 5 (8%) | 5 (7%) | NA† |
Aseptic loosening | 11 (17%) | 45 (63%) | |
Periprosthetic fracture | 20 (31%) | 3 (4%) | |
Infection | 7 (11%) | 5 (7%) | |
Dislocation | 5 (8%) | 10 (14%) | |
Failure of bone ingrowth | 12 (19%) | 0 (0%) | |
Mechanical failure/breakage | 1 (2%) | 1 (1%) | |
Instability | 0 (0%) | 2 (3%) | |
Pain | 2 (3%) | 0 (0%) | |
Other | 1 (2%) | 0 (0%) |
* Probability values were calculated using the Wilcoxon rank-sum test for continuous variables and the Pearson’s chi-square test for categorical variables; † too many categories to calculate a meaningful p value; NA = not applicable.